Collegium Pharmaceutical, Inc
COLL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001267565
No open-market purchases or sales by Collegium Pharmaceutical, Inc insiders were filed in the last 90 days; 279 institutions reported holding it in 13F filings for Q2 2026, worth $1.42B in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Collegium Pharmaceutical, Inc changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 229 | 1 | 249 | +21 |
| Shares | 39.6M | 5.79M | 38.5M | +4.66M (+13.8%) |
| Value | $1.28B | $186.5M | $1.49B | +$397.5M (+36.5%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (40)
Institutions that held Collegium Pharmaceutical, Inc at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (19)
Institutions that held Collegium Pharmaceutical, Inc at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Tejara Capital Ltd | 124,700 | $4.02M |
| Avidity Partners Management LP | 117,000 | $3.77M |
| Marshall Wace, LLP | 70,964 | $2.29M |
| Jump Financial, LLC | 44,776 | $1.44M |
| Campbell & CO Investment Adviser LLC | 41,704 | $1.34M |
| Maverick Capital LtdSuperinvestorMaverick Capital | 39,596 | $1.27M |
| Guggenheim Capital LLC | 32,038 | $1.03M |
| Natixis Advisors, L.P. | 24,665 | $794.0K |
| Centiva Capital, LP | 24,568 | $791.1K |
| Capula Management Ltd | 22,457 | $723.1K |
| Sherbrooke Park Advisers LLC | 18,990 | $611.5K |
| Graham Capital Management, L.P. | 17,341 | $558.4K |
| Twinbeech Capital LP | 16,039 | $516.5K |
| Trexquant Investment LP | 15,806 | $509.0K |
| Quantbot Technologies LP | 10,470 | $337.1K |
| Engineers Gate Manager LP | 9,414 | $303.1K |
| Omers Administration Corp | 7,900 | $254.4K |
| Corton Capital Inc. | 7,555 | $243.3K |
| nVerses Capital, LLC | 1,700 | $54.7K |
Not filed for Q3 2024 yet (1)
Institutions that held Collegium Pharmaceutical, Inc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 5,793,383 | $186.5M |